Savara (SVRA) Long-Term Debt Repayments (2015 - 2025)
Savara (SVRA) reported Long-Term Debt Repayments of -$1000.0 for Q3 2025, down 100.0% on a QoQ basis from $27.2 million in Q1 2025.
Savara (SVRA) has 7 years of Long-Term Debt Repayments data on file, last reported at -$1000.0 in Q3 2025.
- Quarterly Long-Term Debt Repayments changed N/A year-over-year to -$1000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $27.2 million (changed N/A YoY) and the FY2025 annual result came in at $27.2 million, changed N/A from the prior year.
- Long-Term Debt Repayments fell to -$1000.0 in Q3 2025 per SVRA's latest filing, from $27.2 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $27.2 million in Q1 2025 and bottomed at -$1000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Mar 31, 2025 | 27.23 Mn |
| Mar 31, 2025 | 27.23 Mn |
| Mar 31, 2020 | 514,000.00 |
| Mar 31, 2020 | 514,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Dec 31, 2018 | 289,000.00 |
| Dec 31, 2018 | 289,000.00 |
| Sep 30, 2018 | -1,000.00 |
| Sep 30, 2018 | -1,000.00 |
| Jun 30, 2018 | 15,000.00 |
| Jun 30, 2018 | 15,000.00 |
| Mar 31, 2018 | 243,000.00 |
| Mar 31, 2018 | 243,000.00 |
| Dec 31, 2017 | -3.11 Mn |
| Dec 31, 2017 | -3.11 Mn |
| Jun 30, 2017 | -21.43 Mn |
| Jun 30, 2017 | -21.43 Mn |
| Mar 31, 2017 | 3,000.00 |
| Mar 31, 2017 | 3,000.00 |
| Jun 30, 2016 | 79,000.00 |
| Jun 30, 2016 | 79,000.00 |
| Mar 31, 2016 | 2,000.00 |
| Mar 31, 2016 | 2,000.00 |
| Dec 31, 2015 | 2,000.00 |
| Dec 31, 2015 | 2,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Jun 30, 2015 | 1,000.00 |
| Jun 30, 2015 | 1,000.00 |
| Mar 31, 2015 | 2,000.00 |
| Mar 31, 2015 | 2,000.00 |